Globus Medical Inc
GMED· NYSE
GMEDGlobus Medical Inc
Released Aug 4, 2021, after the close
10-Q filed Aug 4, 2021, 35 days after period end · 0001562762-21-000298
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Revenue | $251.02M | $148.92M | $194.54M | $173.38M |
| Net Income | $41.55M | -$20.84M | $38.16M | $44.98M |
| EPS Diluted |
Globus Medical Inc · CIK 1237831 · Engraved from SEC EDGAR
| $0.40 |
| -$0.21 |
| $0.38 |
| $0.44 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
